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proof-of-concept studies to real-world solutions. The challenge
is now to enhance end-user adoption by improving user
friendliness, compatibility, assay ability and product readiness
of these solutions. This review evaluates Organ-on-a-Chip ef-
forts published over the last two years in light of such end-user
adoption aspects. Elegant platforms have been reported
including a microtiter plate-based 3D cell culture platform and
a platform of cantilevers with integrated gauge sensors for
contractility measurement. Also functional assays for angio-
genesis, calcium imaging of neurons and neuro-muscular
contractility were reported. Compatibility with standard anal-
ysis techniques such as sequencing, fluorescent activated cell
sorting and mass spectrometry were reported only in rare
cases. It is concluded that the elements that enable the leap
towards end-user adoption are in place, but only few systems
have managed to incorporate all aspects, and are able to
answer biological questions.Addresses
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Organ-on-a-Chip has recently emerged as a new para-
digm in enhanced cell culture [1]. The field builds on
almost 25 years of developments in microfluidic and
associated microfabrication techniques on the one hand
and an urge towards ever more physiologically relevant
cell culture on the other hand [2,3]. Application ofwww.sciencedirect.commicroengineering techniques in cell culture enables the
use of flow and associated sheer stress, mechanical strain
and allows integration of sensors and systems such as,
sample preparation aspects, automated dosing and
dilution series preparation. It also facilitates co-culture,
3D culture and application of controlled gradients.
Earliest work in microfluidic cell culture appeared
around the turn of the century and includes perfused
Transwell systems, multi-organ systems and 3D liver
tissue [4e7]. Although many applications have been
developed over the last 15 years, it was not until the
paradigm shifting Lung-on-a-Chip publication of the
Ingber group in 2010 that one could identify Organs-on-
Chips as a field in its own right [8]. Since then, the field
has expanded tremendously, both in terms of academic
publications as well as commercial offerings.
In our 2015 review article, we concluded that the field is
currently shifting from a technology focus, aiming to
develop prototypes and concepts, towards a biology
focus, whereby validation of culture systems and inte-
gration of state-of-the-art stem cell and cell culture
techniques are key [9]. With this transition towards an
application focus, the question poses itself: what efforts
are ongoing to promote end-user adoption?
In this critical review, we attempt to take an end-user
perspective on Organ-on-a-Chip developments and
make an inventory of instrument compatibility, ease of
handling, and adoption readiness aspects. In addition,
we consider the type of assays that are typically carried
out in, or on samples from, these systems, providing
insight in the spectrum of techniques that can be
deployed for assessing biological properties and re-
sponses, and to answer biological, clinical or pharmaco-
logical questions.Overview
In this review, we catalogued 77 research articles
containing the keywords (Organ-on-a-chip) OR
(“Organ on a chip”) OR (“microfluidic” AND “cell
culture”), which appeared since 2014 on PubMed.
Papers that were not found with the search string, but
were known to the authors as highly relevant were
added to the database. The articles were categorized
according to on-chip and off-chip assays, integration
aspects, flow control and format in Figure 1 and
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Figure 1
Overview of assays and usability aspects of Organs-on-Chips since 2014. (a–c) Relative scores for the frequency of assays and integrations in Organs-
on-Chips. On-chip assays: Immunohistochemistry scored the highest followed by permeability. Off-chip assays: RNA expression had the highest score,
followed by ELISA. Integration: Other actuators and sensors scored the highest. (d) The distribution of different mechanisms of flow control in Organ-on-
a-Chip. More than half of the developed microfluidic models had external pumps. (e) The distribution of different formats: The majority of Organ-on-a-
Chip models is comprised of single chip concepts.
16 Future of BMEAlthough articles referenced in this paper describe many
aspects of Organ-on-a-Chip systems, we have chosen to
focus solely on usability and compatibility aspects of the
solutions proposed. Physiological relevance of the
various systems has been extensively reviewed else-
where [1,9e11].
Figure 1a and b show spider graphs of assays performed
in Organs-on-Chips, categorized into on-chip and off-
chip assays. On-chip assays include immunohistochem-
istry, permeability, trans epithelial electric resistance
(TEER), migration assays, angiogenesis and other assays
(e.g. calcium imaging, colorimetric and luminescence).
Off-chip assays consist of enzyme-linked immunosor-
bent assays (ELISA), luminescence, liquid/gas chroma-
tographyemass spectrometry ((LC/GC-) MS), RNA
expression and colorimetric assays. Immunohistochem-
ical staining is the dominant on-chip analysis technique.
Almost all publications used immunohistochemical
staining to characterize the physiology of their tissue or
organ models. We assume that also phase-contrast mi-
croscopy is generically used for on-chip assessment of
cell morphology and confluence during culturing, how-
ever we omitted this from our analysis as it is usually not
used as an endpoint or quantified analyses.
RNA expression analysis and ELISA are often used for
assessing cellular responses to flow, co-culture or drug
compounds. Although very well possible to perform suchCurrent Opinion in Biomedical Engineering 2017, 1:15–22techniques on chips, in our analysis we find PCRs and
ELISA to be exclusively performed off-chip. Although
being a highly generic analysis technique, (LC/GC-) MS
is used as a readout for Organs-on-Chips only by few
[12e16].
Off-chip assays have the benefit that they are readily
available and standardized. However, a disadvantage
arises in conjunction with microfluidic chips. Cell cul-
ture volumes are typically quite small and dead-volumes
in comparison are large. This renders the signal-to-noise
ratio low in comparison to classical cell culture tech-
niques. This problem is largely solved by performing
assays on the chip. It is for this reason that immuno-
histochemical staining and other optical readouts are
highly popular. Not only is their implementation rela-
tively straightforward, the microfluidic environment also
assures excellent imaging quality. Other on-chip assays
are reported less often, as they have the disadvantage
that they need to be tailored to the microfluidic envi-
ronment. This puts higher constraints on the engi-
neering skills of the research team, potentially
distracting from biological developments.
Microengineering techniques offer ample opportunities
to integrate actuators, sensors and complex fluid
handling modules on the same chip (see Figure 1c). In
recent Organ-on-a-Chip publications, this is predomi-
nantly done for sensors and actuators. The trend towww.sciencedirect.com
Assays and usability aspects Junaid et al. 17induce or measure mechanical strain has led to a rela-
tively large number of publications that use actuators
other than for integrated pumping [17e19]. Chip-
integrated sensors are predominantly electrochemical
sensors [20e22]. Relatively few number of papers
demonstrate integration of sample preparation aspects
to improve the quality of the readout of assays of cell
cultures [14].
Since the human physiology consists of a dynamic
environment, flow control is a crucial requirement of
Organs-on-Chips. While microengineering techniques
offer ample precedents for integration of pumps on the
chip, the majority of publications make use of external
pumps to drive the flow (see Figure 1d). Although
convenient in a proof-of-concept phase, none of theFigure 2
| Selection of Organ-on-a-Chip systems with particularly interesting usability a
harvesting stem cells and microtissue spheroids. This system is compatible w
machine to accurately and directly sort cells into compartments of the microf
format that comprised 96 microfluidic networks for high-throughput assays. A c
leaving half the chamber for culture medium in a “membrane-free” manner. M
device by Theberge et al. for parallel angiogenesis assays in co-culture. Flow
with eight independent wells. The device was fully 3D printed and integrated
contractions [18].
www.sciencedirect.compublications researched, showed an easy to use approach
for connecting an external pump system by non-expert
end-users. Passive levelling on the other hand is a very
simple technique that is becoming rapidly more popular
to drive flow in microfluidic systems [13,23e26].
Although very simple to use for the non-expert end-user,
the bidirectionality of the flow is seen as a disadvantage
by some. Integration of pumps is an alternative solution
to this [12,27e31].
Strikingly, most publications show Organ-on-a-Chip
concepts on single chips, although it is crucial for end-
user acceptance to include dilution series, replica’s
and positive and negative controls (see Figure 1e). A
small fraction incorporates multiple microfluidic net-
works on a single chip and yet in exceptional situationsspects. (a) Hanging-drop chip network for loading, culturing and
ith optical imaging and fluidic pumps and was integrated with a FACS
luidic network [33]. (b) The OrganoPlate®, a 384-well microtiter plate
apillary pressure barrier enables to pattern the extracellular matrix while
icrofluidic flow was induced by passive levelling [26]. (c) Microfluidic
was facilitated by passive pumping [32]. (d) Microphysiological device
with a strain sensor for continuous electronic readout of cardiac tissue
Current Opinion in Biomedical Engineering 2017, 1:15–22
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compatibility [26,32].Usability aspects
The usability aspects of microfluidic devices relate to
aspects of compatibility to existing equipment, auto-
mation, ease of handling, possibility to generate multi-
ple data points amongst others. We describe here some
selected papers that we feel made particular progress on
one or more of these aspects. For example, Birchler et al.
created an open format hanging-droplet system for
microfluidic handling, culturing of single cells and
microtissue spheroids in multiple culture compartments
(Figure 2a) [33]. Noteworthy, their system was
compatible with fluorescence-activated cell sorting
(FACS) to directly sort cells, without the need of in-
termediate steps, into the desired microfluidic culture
compartments. Cells were sorted corresponding to their
light-scattering characteristics, which enabled the sep-
aration of single cells from cell clusters and assess the
biological structure of cells during loading. The open
microfluidic chip of Birchler et al. gives an agreeable
illustration of a system that is both high-throughput,
compatible and can be coupled with standard cell
biology tools.
Similarly, Wevers et al. reported 3D culturing of
neuronal and glial cells in a high throughput 3D cell
culture platform using a modified 384-well plate to
create 96 independent microfluidic networks for 3D cell
culture (Figure 2b) [26]. The platform employs pas-
sive levelling for fluid exchange and 175 mm thin glass
for enhanced microscopic imaging. The microtiter plate
format renders the platform fully compatible with
standard microscopes, automated readers and robot
handling, an aspect that was utilized by Wevers et al. for
generating dose response curves to toxic compounds.
Moreno et al. also used the same platform to differen-
tiate human iPSC-derived neuroepithelial stem cells
into functional dopaminergic neurons [24]. Jang et al.
used a similar platform for studying drug induced liver
injury [34]. The fact that three different universities
report use of the platform is a strong indication of
transferability of the concept.
Another study reported a chip system for studying
angiogenesis (Figure 2c) [32]. The system consists of
an array of 14 microfluidic networks perfused by passive
pumping. Each microfluidic network has two main
microfluidic channels that are interconnected through
microchannels that are substantially lower than the main
channels (30 mm vs. 330 mm) enabling exchange of
soluble signalling molecules between cells grown in the
two separated channels. The authors studied the effects
of antiangiogenic factor MMP12 and pro-angiogenic
factors secreted by macrophages on endothelial tubule
formation. Pipette operation makes the microfluidicCurrent Opinion in Biomedical Engineering 2017, 1:15–22device simple to use and although not demonstrated in
the publication, the system seems easily made
compatible with liquid handling systems.
Lind et al. used 3D printing to develop an assay
concept for measuring contractility of cardiac tissue
(see Figure 2d) [18]. The system has integrated soft
strain gauge sensors to measure contractile stresses of
multiple cardiac micro-tissues. Each device is
composed of eight independent wells with multilayer
cantilevers, a base layer, an embedded strain sensor, a
tissue-guiding layer and electrical interconnects for
readout. The tissue-guiding layer promotes the self-
assembly of physio-mimetic laminar cardiac tissues.
The system developed by Lind et al. enables non-
invasive real-time electronic readout of contractile
properties inside a cell incubator and can be used to
study dose-response of drugs that influence contractile
strength or beat rate.
An example of a more complex system is reported by
Ramadan et al. [35]. This device contained three par-
allel cell culture chambers and Ag/AgCl electrode wires
to measure TEER of the human skin in vitro under
perfusion of culture media. The barrier integrity of
human keratinocytes was measured in co-culture with
monocytes. A chip comprised three such devices,
although due to external pump and open electrode wire
connections, the operation of the device is primarily
reserved for expert end-users.Functional assays in Organ-on-a-Chip
systems
In vitromicrocirculation, induced by flow, is important to
mimic organ physiology. Kim et al. demonstrated this
with angiogenesis assays in their three-dimensional
culture model [36] (see Figure 3a). Blood endothelial
cells were cultured in a microfluidic platform and
vasculogenesis was stimulated by fibroblast-secreted
pro-angiogenic factors and flow-mediated mechanical
stresses. They found that interstitial flow plays a sig-
nificant role in the growth of angiogenic sprouts. It can
either promote or suppress angiogenic sprouting
depending on the direction of flow (Figure 3a). The
control over gradients of angiogenic factors and appli-
cation of interstitional flow for 3D angiogenic sprouting
is a strong example of an assay that can be exclusively
done by means of microfluidic techniques.
Wang et al. illustrated different stages of vascular
development in a microfluidic system [37]. This system
contained a well-defined hourglass shaped communica-
tion pore that pins fibrin gel at its vertexes and permits
the formation of an endothelial cell monolayer on the
fibrin gel interface. Subsequently, the authors induced
vasculogenesis, endothelial cell lining, sprouting angio-
genesis, and anastomosis by using an optimizedwww.sciencedirect.com
Figure 3
| Noteworthy assays in Organs-on-Chips. (a) Angiogenesis model developed by Kim et al., showing directional prejudice in response to flow direction.
S–N: Downward direction. N–S: Upward direction [36]. (b) Vascularized micro-tumours and their response to drugs. Human colorectal cancer cell line
HCT116 (green) and endothelial cells (red) were visualized by confocal microscopy. The results were translated to IC50 ratios (tumour growth and total
vessel length) [38]. (c) Model of human Airway-on-a-Chip by Benam et al. High-speed microscopic imaging showed the beating activity of the cilia on
the epithelium under healthy condition, asthmatic phenotype, COPD exacerbation and drug treatment [39]. (d) Calcium imaging recordings to detect
electrophysiological activity of neurons. This assay was used to evaluate compounds effect in the high-throughput 3D culture system of Wevers et al.
[26].
Assays and usability aspects Junaid et al. 19interstitial flow and VEGF gradient. This finally enabled
the formation of an intact and perfusable microvascular
network. The system was used for co-culture with
tumour cells for clinical applications [38] (see
Figure 3b). The impact of drugs was assessed on either
the tumour directly or to the microvascular network.
The growth and assaying of perfused 3D vascular net-
works is another example of tissue modelling that is
inherently performed in a microfluidic setting.
Benam et al. elaborated on their initial Lung-on-a-Chip
work to model small airway epithelium comprised of a
co-culture of bronchial epithelium and microvascular
endothelium separated by a membrane [39]. A
particularly elegant assay was implemented to measure
the beating frequency of cilia in response to stimuli.
Figure 3c shows the increase in cilia beating frequency
in response to the drug Tofacitinib. The extra value of
this work in comparison to classical Transwell system is
to be sought in the perfusion of the basal compartment
and the imaging, but this goes at the cost of ease of
handling and throughput.
Wevers et al. demonstrated 3D culture of iPSC-derived
neuronaleglial cells of healthy people and Huntington’s
disease patients in Matrigel, which they showed and
quantified with immunohistochemistry [26]. They
measured cell viability following exposure to several
neurotoxic compounds. Particularly interesting was thewww.sciencedirect.comcompound mediated modulation of electrophysiological
activity that was visualized by calcium imaging (see
Figure 3d).
A visualisation of electrophysiological activity was re-
ported by Müller et al. who developed a CMOS chip
with high density electrodes to measure spatial voltage
distribution at a 17.5 mm resolution [40]. Each electrode
was used to measure the electrical activity of individual
neurons. Noteworthy, an elegant indirect readout for
electrophysiological activity was reported by Uzel et al.
that used photosensitized embryonic stem cells to
differentiate into neurospheres and interact with
muscle tissue [19]. Photostimulation or glutamate
addition caused the muscle to contract as a consequence
of action potentials that could be measured by deflec-
tion of microfabricated pillars.
Herland et al. demonstrated a blood-brain barrier, the
barrier function thereof could be interrogated by leakage
of 3 kDa FITC labelled dextran and calculating the Papp
value thereof [41].
Chen et al. reported a microfluidic cell culture chip,
made of four microchannels and Petri dish-based cell
medium supply system that was used to measure cell
migration [42]. They were successful in screening
highly metastatic sublines in their system. Interestingly,
to perform parallel cell migration with different modes,Current Opinion in Biomedical Engineering 2017, 1:15–22
20 Future of BMEMa et al. created a microfluidic system that combines
membrane-based cell migration and droplet-based
techniques [43]. Droplets were adjacently positioned
on either side of a membrane, enabling gradient for-
mation that was exploited in migration assays. Conse-
quently, multi-parametric gradients were constructed
for metastatic assays. The concept allowed multiple in-
droplet operations in the nanoliter range and up to 81
assays in parallel.Molecular assays in Organ-on-a-Chip
systems
Organ-on-a-Chip based models have been extensively
analysed with help of molecular assays such as ELISA,
RNA expression analysis, probing metabolism and
immunohistochemistry [14,44e46]. A particular exten-
sive analysis was done by Kamei et al. who performed
global gene expression analysis on human embryonic
stem cells and induced pluripotent stem cells that were
cultured in a 3D thermo responsive hydrogel in a
microfluidic channel [47].
Patra et al. analysed 5000 3D tumour spheroids using
flow cytometry after dissociation of the tumour [25]. In
that context, they could perform single cell analysis
which they correlated to tumour size, 2D or 3D culture
as well as therapy response based on Calcein AM
(healthy) and 7-Amino-ActinomycinD (necrosis) and
APC-Annexin V (apoptosis). The assays demonstrate
the power of large numbers using flow-cytometry, which
is a standard instrument in modern cell biology.
A compatible assay setup was demonstrated by Bavli
et al. who could distinguish between cell death, healthy
cells and on-set of mitochondrial dysfunction in real-
time by measuring glucose, lactate and oxygen [48].
Oxygen was measured by tissue embedded Ru-CPOx
oxygen sensors, while glucose and lactate measured by
amperometric detection of glucose and lactate oxidase
mediated oxidation of H2O2. Time-resolved sampling
was supported by an off-chip microfluidic switchboard.
The switchboard also enabled automated calibration of
the amperometric sensing scheme. Similar electro-
chemical recordings were demonstrated by Misun et al.
in conjunction with hanging drop-based cell culture
[22]. The authors project their setup for real-time
monitoring applications of glucose and lactate in Body-
on-a-Chip type setups.
A rare example of coupling LC/MS based metabolomics
techniques with microfluidic cell culture is given by
Filla et al. However, no in depth biological analysis was
demonstrated in their report [14].
Although being impressive examples in terms of
complexity of the assays, the added value of the
microfluidics is still limited in many of the aboveCurrent Opinion in Biomedical Engineering 2017, 1:15–22examples. Kamei et al. did not use any of the flow as-
pects, while both Patra, Bavli and Kamei et al. did not
consider co-culture or other aspects that render 3D cell
culture more physiologically relevant [25,47,48].Conclusions and future directions
In this article, we assessed usability, compatibility and
assay ability aspects in recent Organ-on-a-Chip publi-
cations. We discussed examples of efforts to improve
usability, incorporate unique assays, or informative ana-
lyses using standard laboratory techniques. However,
only in rare examples an Organ-on-a-Chip concept ticks
all the boxes and can be considered ready for transfer to
an end-user. On the contrary, the majority of publica-
tions reported single chip-based models, external
pumping and use immunohistochemical stains as pri-
mary readout. In the review article of van Duinen et al.
we concluded that with maturation of the microfluidics
field, the focus in Organ-on-a-Chip studies will shift
towards validation of models and integration of newest
stem cell techniques [9]. Thus, the multidisciplinary
field will become more and more the realm of biologists.
However, with an increasing role of biologists in the
field, attention for usability aspects, throughput and
compatibility is critical. Moreover, compatibility with
the full width of biochemical analysis techniques is
crucial in order to enhance end-user adoption and full
validation of the models. Last but not least, availability
of these systems, either in commercial form, or at least
producible in significant numbers becomes critical,
enabling the end-user to perform his/her optimisation
research.
We envision that in coming years, the end-user aspects
will dominate engineering aspects in the Organ-on-a-
Chip field and that commercial providers will be play-
ing an increasingly dominant role. The availability of
easy-to-operate, mass produced systems will enable
end-users to focus on what they do best: excellent
biology, validation of the models and screening for better
medicines. And this will require the availability of
proper molecular or physiological readouts to answer
clinical, biomedical or biological questions.Acknowledgements
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